Jpmorgan Chase & CO Conmed Corp Transaction History
Jpmorgan Chase & CO
- $1.22 Trillion
- Q3 2024
A detailed history of Jpmorgan Chase & CO transactions in Conmed Corp stock. As of the latest transaction made, Jpmorgan Chase & CO holds 424,746 shares of CNMD stock, worth $31.8 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
424,746
Previous 313,795
35.36%
Holding current value
$31.8 Million
Previous $21.8 Million
40.43%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding CNMD
# of Institutions
307Shares Held
33.7MCall Options Held
123KPut Options Held
24.2K-
Black Rock Inc. New York, NY4.99MShares$374 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.53MShares$264 Million0.0% of portfolio
-
Earnest Partners LLC Atlanta, GA2.78MShares$209 Million0.91% of portfolio
-
Capital Research Global Investors Los Angeles, CA1.54MShares$116 Million0.02% of portfolio
-
Bank Of America Corp Charlotte, NC1.37MShares$103 Million0.01% of portfolio
About CONMED Corp
- Ticker CNMD
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 30,482,400
- Market Cap $2.28B
- Description
- CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. It offers orthopedic surgery products, including TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and PopLok Knotless Suture Anchors, which provide uni...